Stay updated with breaking news from Procaps Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid PortfolioPreliminary Results for 1Q23 Show a Significant Rebound from 4Q22 Performance, Company Expects to Reach at Least High Single-Digit Growth in Adjusted EBITDA...
Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Portfolio Preliminary Results for 1Q23 Show a... | June 14, 2023
MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that
MIAMI and BARRANQUILLA, Colombia, May 01, 2023 -- Procaps Group, S.A. , a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will file its Form 20-F and... | May 1, 2023
Shares of Procaps Group S.A. (NASDAQ:PROC – Get Rating) gapped up before the market opened on Wednesday . The stock had previously closed at $4.61, but opened at $4.80. Procaps Group shares last traded at $4.80, with a volume of 1,735 shares trading hands. Procaps Group Stock Performance The business’s 50 day simple moving average […]